| Product classification | Laser and intense pulsed light devices are regulated differently by jurisdiction. The product technology, intended use, risk profile and claims determine the applicable pathway. | Hair-removal devices may require an FDA marketing authorization pathway. The exact product code and submission route depend on the device design and intended use; 510(k) clearance is commonly relevant for comparable medical devices. | Devices are regulated under Regulation (EU) 2017/745. Products intended for hair removal only may fall under the rules applicable to certain aesthetic devices listed in Annex XVI, while devices with medical claims may have a different classification. | Great Britain generally uses the UK Medical Devices Regulations 2002, as amended. UKCA requirements and transitional arrangements depend on the product, conformity route and applicable market date. | Canada commonly requires a Medical Device Licence for Class II, III or IV devices. Australia generally requires inclusion in the Australian Register of Therapeutic Goods when the product is a regulated medical device. |
| Core electrical safety | IEC 60601-1 is the principal general standard for basic safety and essential performance of medical electrical equipment. | Testing is commonly performed against applicable IEC 60601 requirements, with national deviations and FDA-recognized consensus standards considered where relevant. | EN 60601-1 and applicable collateral or particular standards support demonstration of conformity under the EU framework. | BS EN 60601-1 or the applicable designated standard is commonly used as technical evidence, subject to the selected conformity route. | Local regulators generally accept internationally recognized electrical safety evidence when it is applicable to the device and supported by a complete technical file. |
| Laser safety | IEC 60825-1 covers laser product classification and safety requirements. IEC 60601-2-22 is relevant to certain medical laser equipment, where applicable. | The manufacturer should document laser classification, accessible emission limits, protective housing, interlocks, labeling and user instructions. | Laser safety evidence should align with the applicable harmonized or recognized standards and the device's intended use. | The technical documentation should address laser classification, optical hazards, controls, labeling and operator protection. | Evidence should cover optical output, protective measures, warnings, service procedures and compliance with the relevant national adoption of IEC laser standards. |
| EMC and electromagnetic immunity | IEC 60601-1-2 addresses electromagnetic compatibility for medical electrical equipment. | Manufacturers should provide emissions and immunity test reports, including the operating configurations and accessories used during testing. | EMC performance is part of the essential safety and performance evidence required for conformity assessment. | EMC documentation should reflect the applicable UK conformity requirements and the final marketed configuration. | Importers and distributors should verify that EMC reports cover the exact model, power configuration and accessories supplied in the target market. |
| Quality management system | ISO 13485 is the principal international quality-management reference for medical-device design, production and post-market processes. | A manufacturer must maintain a quality system meeting applicable FDA quality-system requirements; ISO 13485 certification can support, but does not automatically replace, regulatory obligations. | An ISO 13485-based system is widely used to control design, manufacturing, supplier management, complaint handling and corrective actions. | The manufacturer should maintain documented quality processes that satisfy the applicable UK medical-device requirements. | Quality-system expectations vary by device class and conformity route; documented design controls and supplier controls are fundamental. |
| Biocompatibility and skin-contact materials | ISO 10993 series may apply to patient-contacting materials, including cooling tips, windows, gels or reusable accessories. | Biological evaluation should be risk-based and supported by material specifications, contact-duration assessment and appropriate test reports. | The technical file should justify the biological safety of materials that contact intact or compromised skin. | Material safety evidence should match the intended contact type, duration and cleaning or disinfection process. | The importer should confirm that supplied accessories and consumables are covered by the same safety assessment as the main device. |
| Risk management | ISO 14971 provides the recognized framework for identifying hazards, estimating risks, applying controls and monitoring residual risk. | The risk file should address burns, pigment changes, eye injury, electrical shock, infection, misuse, software faults and incorrect treatment parameters. | Risk controls should be linked to the device's essential safety and performance requirements and clinical or performance evidence. | Risk management should cover foreseeable misuse, training, maintenance, cybersecurity where applicable and post-market feedback. | A complete risk-management file is typically reviewed alongside labeling, usability evidence, verification tests and complaint records. |
| Clinical and performance evidence | Evidence should substantiate claimed hair-reduction performance, treatment consistency, skin-type limitations and foreseeable adverse effects. | Marketing claims should be consistent with the cleared or authorized intended use and supported by bench, clinical or comparative evidence as required. | Clinical evaluation and performance documentation should support the intended purpose and stated benefits under the EU regulatory framework. | The manufacturer should maintain evidence supporting safety, performance and the accuracy of all promotional claims. | Evidence requirements depend on classification, claims and regulator review; unsupported claims can create compliance and liability risks. |
| User protection features | Important controls include skin-contact detection, adjustable energy limits, cooling, emergency stop, treatment counters, password access and eye-protection instructions. | The device should prevent or reduce foreseeable incorrect operation and clearly identify contraindications, warnings and required protective equipment. | Safety-related software and protective functions should be verified and validated for the marketed configuration. | Instructions should specify operator training, skin assessment, patch testing where appropriate, maintenance and emergency procedures. | Local rules may also address operator qualifications, workplace safety and the use of protective eyewear. |
| Labeling and technical documentation | The file should include specifications, drawings, software information, test reports, risk analysis, labeling, instructions and traceability records. | Labeling must identify the device, intended use, warnings, operating limits, manufacturer information and applicable regulatory identifiers. | EU documentation normally includes a technical file, declaration of conformity, applicable conformity assessment records and required labeling. | UK documentation should support the selected UK conformity route and include market-specific responsible-person information where required. | Language, importer details, registration information and labeling format should be checked separately for each destination market. |
| Post-market surveillance | A reliable manufacturer should maintain complaint handling, incident reporting, corrective-action, service and product-traceability processes. | Manufacturers must follow applicable medical-device reporting, correction, removal and post-market obligations. | Post-market surveillance, vigilance and corrective-action procedures are required under the EU framework and should be proportionate to device risk. | The manufacturer and relevant UK economic operators should maintain procedures for complaints, incidents, field safety actions and trend monitoring. | Registration holders, manufacturers, importers and sponsors may have continuing reporting and record-keeping responsibilities. |
| Recommended supplier verification documents | Request certificates with scope and validity, complete test reports, declaration of conformity, risk summary, user manual, warranty terms and service records. | Verify the actual regulatory listing or clearance information rather than relying only on a general certificate or marketing statement. | Check the conformity assessment route, notified-body information where applicable, declaration of conformity and economic-operator details. | Confirm the accepted conformity marking, responsible-person arrangements and transitional eligibility for the intended market date. | Confirm local registration or licensing status, authorized importer details, warranty support and availability of trained technical service personnel. |
